59 related articles for article (PubMed ID: 27139836)
1. Contrasting exome constancy and regulatory region variation in the gene encoding CYP3A4: an examination of the extent and potential implications.
Creemer OJ; Ansari-Pour N; Ekong R; Tarekegn A; Plaster C; Bains RK; Itan Y; Bekele E; Bradman N
Pharmacogenet Genomics; 2016 Jun; 26(6):255-70. PubMed ID: 27139836
[TBL] [Abstract][Full Text] [Related]
2. Genetic contribution to variable human CYP3A-mediated metabolism.
Lamba JK; Lin YS; Schuetz EG; Thummel KE
Adv Drug Deliv Rev; 2002 Nov; 54(10):1271-94. PubMed ID: 12406645
[TBL] [Abstract][Full Text] [Related]
3. CYP3A4 and CYP3A5 genotyping by Pyrosequencing.
Garsa AA; McLeod HL; Marsh S
BMC Med Genet; 2005 May; 6():19. PubMed ID: 15882469
[TBL] [Abstract][Full Text] [Related]
4. Genetic signature consistent with selection against the CYP3A4*1B allele in non-African populations.
Schirmer M; Toliat MR; Haberl M; Suk A; Kamdem LK; Klein K; Brockmöller J; Nürnberg P; Zanger UM; Wojnowski L
Pharmacogenet Genomics; 2006 Jan; 16(1):59-71. PubMed ID: 16344723
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants of CYP3A4 and CYP3A5 in cynomolgus and rhesus macaques.
Uno Y; Matsushita A; Osada N; Uehara S; Kohara S; Nagata R; Fukuzaki K; Utoh M; Murayama N; Yamazaki H
Drug Metab Dispos; 2010 Feb; 38(2):209-14. PubMed ID: 19910514
[TBL] [Abstract][Full Text] [Related]
6. Genetic diversity of CYP3A4 and CYP3A5 polymorphisms in North African populations from Morocco and Tunisia.
Novillo A; Romero-Lorca A; Gaibar M; Bahri R; Harich N; Sánchez-Cuenca D; Esteban E; Fernández-Santander A
Int J Biol Markers; 2015 Feb; 30(1):e148-51. PubMed ID: 25385241
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of the CYP3A4, CYP3A5, CYP3A7 and CYP1A2 among the Jordanian population.
Salameh G; Al Hadidi K; El Khateeb M
Environ Toxicol Pharmacol; 2012 Jul; 34(1):23-33. PubMed ID: 22426036
[TBL] [Abstract][Full Text] [Related]
8. Regulatory variants in a novel distal enhancer regulate the expression of CYP3A4 and CYP3A5.
Collins JM; Nworu AC; Mohammad SJ; Li L; Li C; Li C; Schwendeman E; Cefalu M; Abdel-Rasoul M; Sun JW; Smith SA; Wang D
Clin Transl Sci; 2022 Nov; 15(11):2720-2731. PubMed ID: 36045613
[TBL] [Abstract][Full Text] [Related]
9. CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C allele.
Sim SC; Edwards RJ; Boobis AR; Ingelman-Sundberg M
Pharmacogenet Genomics; 2005 Sep; 15(9):625-31. PubMed ID: 16041241
[TBL] [Abstract][Full Text] [Related]
10. A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1.
Rodriguez-Antona C; Axelson M; Otter C; Rane A; Ingelman-Sundberg M
J Biol Chem; 2005 Aug; 280(31):28324-31. PubMed ID: 15937338
[TBL] [Abstract][Full Text] [Related]
11. The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test.
Oneda B; Crettol S; Jaquenoud Sirot E; Bochud M; Ansermot N; Eap CB
Pharmacogenet Genomics; 2009 Nov; 19(11):877-83. PubMed ID: 19801957
[TBL] [Abstract][Full Text] [Related]
12. CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer.
Plummer SJ; Conti DV; Paris PL; Curran AP; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):928-32. PubMed ID: 14504207
[TBL] [Abstract][Full Text] [Related]
13. Sequence of the 5'-flanking region of CYP3A5: comparative analysis with CYP3A4 and CYP3A7.
Jounaïdi Y; Guzelian PS; Maurel P; Vilarem MJ
Biochem Biophys Res Commun; 1994 Dec; 205(3):1741-7. PubMed ID: 7811260
[TBL] [Abstract][Full Text] [Related]
14. Variation in Expression of Cytochrome P450 3A Isoforms and Toxicological Effects: Endo- and Exogenous Substances as Regulatory Factors and Substrates.
Fujino C; Sanoh S; Katsura T
Biol Pharm Bull; 2021; 44(11):1617-1634. PubMed ID: 34719640
[TBL] [Abstract][Full Text] [Related]
15. Unique CYP3A4 genetic variant in Brazilian tuberculosis patients with/without HIV.
Jeovanio-Silva AL; Monteiro TP; El-Jaick KB; do Brasil PE; Rolla VC; de Castro L
Mol Med Rep; 2012 Jan; 5(1):153-61. PubMed ID: 21964586
[TBL] [Abstract][Full Text] [Related]
16. Differences in CYP3A41G genotype distribution and haplotypes of CYP3A4, CYP3A5 and CYP3A7 in 3 Chinese populations.
Du J; Yu L; Wang L; Zhang A; Shu A; Xu L; Xu M; Shi Y; Li X; Feng G; Xing Q; He L
Clin Chim Acta; 2007 Aug; 383(1-2):172-4. PubMed ID: 17582393
[No Abstract] [Full Text] [Related]
17. Developmental regulation of CYP3A4 and CYP3A7 in Chinese Han population.
He H; Nie YL; Li JF; Meng XG; Yang WH; Chen YL; Wang SJ; Ma X; Kan QC; Zhang LR
Drug Metab Pharmacokinet; 2016 Dec; 31(6):433-444. PubMed ID: 27727071
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cytochrome P450 3A4 by small vault RNAb derived from the non-coding vault RNA1 of multidrug resistance-linked vault particle.
Meng C; Wei Z; Zhang Y; Yan L; He H; Zhang L; Xing Q
Mol Med Rep; 2016 Jul; 14(1):387-93. PubMed ID: 27177257
[TBL] [Abstract][Full Text] [Related]
19. Molecular population genetics of human CYP3A locus: signatures of positive selection and implications for evolutionary environmental medicine.
Chen X; Wang H; Zhou G; Zhang X; Dong X; Zhi L; Jin L; He F
Environ Health Perspect; 2009 Oct; 117(10):1541-8. PubMed ID: 20019904
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of Cytosine Methylation in the Proximal Promoters of CYP3A4 and CYP3A7 in Pediatric and Prenatal Livers.
Vyhlidal CA; Bi C; Ye SQ; Leeder JS
Drug Metab Dispos; 2016 Jul; 44(7):1020-6. PubMed ID: 26772622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
